Mclean Hospital

Genetics Related Content


Researchers Challenge Genetic Tests for Guiding Psychiatric Treatment

In a paper published in JAMA Psychiatry, McLean Hospital’s Program for Neuropsychiatric Research director Bruce M. Cohen, MD, PhD, and his colleagues, George S. Zubenko, MD, PhD, University of Pittsburgh School of Medicine (retired), and Barbara R.M. Sommer, MD, Stanford University School of Medicine, emerita, reviewed the scientific basis and effectiveness of pharmacogenetic (Pgen) tests...

PTSD: Can Genetics Affect Your Risk?

A majority of the US population is exposed to a psychological trauma during their life. For certain people, such as police officers, firefighters, or soldiers, the risk of experiencing trauma is even greater. However, only a fraction of those who experience such events will develop post-traumatic stress disorder (PTSD) or other trauma-related psychiatric disorders. The diagnostic criteria for...

Guia Guffanti Masetti, PhD

Guia Guffanti Masetti, PhD, was a post-doctoral fellow at University of California, Irvine from 2009-2010. For 5 years thereafter, she was assistant professor of clinical neurobiology at the Department of Psychiatry of Columbia University. Her primary research interests are in the area of human genetics with application to the study of genetic variants underlying neuropsychiatric complex...

Mei-Hua Hall, PhD

Mei-Hua Hall, PhD, is the director of the Psychosis Neurobiology Laboratory. Her specific expertise is in electrophysiology, psychiatric genetics, and cognitive neuroscience and she also has a broad background in clinical psychology, epidemiology, and statistical modeling. She receives funding from the National Institute of Mental Health and other sources for her research. Dr. Hall uses...

Deborah L. Levy, PhD

Deborah L. Levy, PhD, has a national and international reputation in the area of psychotic disorders, especially schizophrenia and bipolar disorder. The primary focus of her research is identifying risk genes and understanding their biological actions. Dr. Levy has been a clinical and research psychologist on the staff at McLean since 1991, and has served on the editorial board of various...

Zhicheng (Carl) Lin, PhD

Dr. Lin is currently a grantee of both NIH and Fulbright, with a long-term interest in reducing the prevalence of substance abuse around the world. Dr. Lin’s research focuses on delineation of environmentally related genomic risks for substance abuse, through mapping out molecular pathways that translate external risks into regulated gene activity in the dopaminergic system, and related to...